Sangart Lands $50,000,000 Series F Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    6175 Lusk Blvd San Diego, CA 92121
  • Company Description
    Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series F
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.